GGA
PFE icon

Granite Group Advisors’s Pfizer PFE Stock Holding History

Granite Group Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47,033
Closed -$1.19M – 81
2025
Q1 		$1.19M Buy
47,033
+12,919
+38% +$338K 0.83% 26
2024
Q4 		$905K Sell
34,114
-9,730
-22% -$264K 0.58% 29
2024
Q3 		$1.27M Sell
43,844
-1,042
-2% -$30.4K 0.82% 27
2024
Q2 		$1.26M Buy
44,886
+1,995
+5% +$54.9K 0.95% 26
2024
Q1 		$1.19M Sell
42,891
-145
-0.3% -$4.02K 0.8% 28
2023
Q4 		$1.22M Buy
+43,036
New +$1.3M 0.86% 28

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Granite Group Advisors's PFE Position: Q2 2025 in Review

Granite Group Advisors sold out of Pfizer (PFE) in Q2 2025, closing a stake of 47,033 shares — an estimated $1.19M sold.

Granite Group Advisors first reported a position in PFE in Q4 2023 and held it in 6 quarters. The position peaked at $1.27M in Q3 2024. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Granite Group Advisors reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Granite Group Advisors sold 47,033 Pfizer shares in Q2 2025, an estimated $1.19M.
  • Granite Group Advisors first reported a position in Pfizer in Q4 2023 and held it in 6 quarters.
  • Granite Group Advisors's Pfizer position peaked at $1.27M in Q3 2024.
  • 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Granite Group Advisors's 13F filing for Q2 2025, filed 28 Jul 2025.